Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer
The most common oncogenic driver in non-small-cell lung cancer (NSCLC) is the epidermal growth factor receptor (EGFR) gene mutations that occur more frequently among Asians (30%–50%) as opposed to Caucasians (10%–15%). Lung cancer is one of the most prevalent cancers in India, with a reported adenoc...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2023-07-01
|
| Col·lecció: | BMJ Open Respiratory Research |
| Accés en línia: | https://bmjopenrespres.bmj.com/content/10/1/e001492.full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|